The article reports on the raising of the venture financing funds of the Viral Logic Systems Technology in Seattle, Washington. The increase on its capital funds is intended for the financing of the biotechnological researches. In addition, it was found that venture investors are looking to back up the commercialization of the biotechnology and life sciences.